Impact of a practice guideline for patients with atrial fibrillation on medical resource utilization and costs

American Journal of Cardiology

Volumn 92, Issue 6, 2003, Pages 677-681

  Zimetbaum, Peter ^a,b   Reynolds, Matthew R ^a   Ho, Kalon K L ^a   Gaziano, Thomas ^a   McDonald, Mary Jane ^a   McClennen, Seth ^a   Berezin, Ronna ^a   Josephson, Mark E ^a   Cohen, David J ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT;

ARTICLE; CARDIOVERSION; CONTROLLED STUDY; DEATH; ELECTROPHYSIOLOGY; EMERGENCY WARD; EXERCISE TEST; FINANCIAL MANAGEMENT; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH ECONOMICS; HEART ATRIUM FIBRILLATION; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; OUTPATIENT; PATIENT REFERRAL; PRACTICE GUIDELINE; PRIORITY JOURNAL; STROKE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY;

EID: 0042335640     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(03)00821-X     Document Type: Article

References (8)

1. Lok N.-S., Lau C.-P. Presentation and management of patients admitted with atrial fibrillation a review of 291 cases in a regional hospital. Int J Cardiol. 48:1995;271-278.
2. Dell'Orfano J.T., Patel H., Wolbrette D.L., Luck J.C., Naccarelli G.V. Acute treatment of atrial fibrillation spontaneous conversion rates and cost of care. Am J Cardiol. 83:1999;788-790.
3. Zimetbaum P., Josephson M.E., McDonald M.J., McClennen S., Korley V., Ho K.K.L., Papageorgiou P., Cohen D.J. Incidence and predictors of myocardial infarction among patients with atrial fibrillation. J Am Coll Cardiol. 36:2000;1223-1227.
4. McCaig LF, Burt CW. National Hospital Ambulatory Medical Care Survey: 1999. Emergency Department Summary Advance Data from Vital and Health Statistics. Hyattesville, MD: National Center for Health Statistics, 2001.
5. Finkler S.A. The distinction between costs and charges. Ann Int Med. 96:1982;102-109.
6. Peterson E.D., Cowper P.A., DeLong E.R., Zidar J.P., Stack R.S., Mark D.B. Acute and long-term cost implications of coronary stenting. J Am Coll Cardiol. 33:1999;1610-1618.
7. Eckman M.H., Falk R.H., Pauker S.G. Cost-effectiveness of therapies for patients with nonvalvular atrial fibrillation. Arch Intern Med. 158:1998;1669-1677.
8. Kim M.H., Morady F., Conlon B., Kronick S., Lowell M., Bruckman D., Armstrong W.F., Eagle K. A prospective, randomized, controlled trial of an emergency department-based atrial fibrillation treatment strategy with low-molecular weight heparin. Ann Emerg Med. 40:2002;187-192.